COMMUNIQUÉS West-GlobeNewswire

-
Cannara Biotech organise une webdiffusion pour les investisseurs le 25 juin 2025
19/06/2025 -
Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant Congress
19/06/2025 -
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/06/2025 -
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
19/06/2025 -
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
19/06/2025 -
VitalHub Completes Acquisition of Induction
19/06/2025 -
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
19/06/2025 -
CrazyBulk “Legal Steroid Alternatives” for Muscle Growth: A Safer Shift in Bodybuilding and Performance Nutrition 2025
19/06/2025 -
Catholic Health Teams Up with Olympic Gold Medalist Katie Ledecky to Help Patients Optimize Their Health
19/06/2025 -
Verano Announces Exclusive Partnership with Award-Winning Arizona Cannabis Operator Grow Sciences to Bring its Best-In-Class Products to Illinois
19/06/2025 -
Symbiotic.blue Launches to Combine Oxford and Cambridge Scientific Brain Power with Bioentrepreneurial Leadership to Reinvent AI Drug Discovery
19/06/2025 -
HLTH Inc. Unveils HLTH.rad — A Bold New Global Gathering for Imaging Innovators Co-Located with HLTH Europe 2026 in Amsterdam
19/06/2025 -
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
19/06/2025 -
Major shareholder announcement
19/06/2025 -
VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025
19/06/2025 -
VIRBAC: Paul Martingell nommé directeur général du groupe Virbac au 1er septembre 2025
19/06/2025 -
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
19/06/2025 -
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares
18/06/2025 -
Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering
18/06/2025
Pages